2012 Progress and Controversies in Gynecologic Malignancies Conference

Home

Faculty

Agenda

Hotel

Registration

General Information

Contact

Overview

On behalf of the Scientific Committee, we are pleased to invite you to the 2012 Progress and Controversies in Gynecologic Oncology Conference, to be held in Barcelona, Spain, on 13–14 April 2012.

This meeting will serve as a valuable forum for the presentation and discussion of newly available data across various gynecologic malignancies including ovarian, cervical, and endometrial cancers. Participants will be provided with updates on practice-changing data in a practical and interactive format, fostering discussion, and impacting clinical outcomes for patients.

Who Should Attend
The 2012 Progress and Controversies in Gynecologic Oncology Conference, is intended for gynecologists, oncologists, radiation therapists, surgeons, pathologists, and other practitioners including allied health professionals involved in the diagnosis and management of gynecologic malignancies.

Learning objectives

After successful completion of this educational activity, participants should be able to:

• Develop a practical approach to cervical cancer staging and disease management

• Discuss the role of radiotherapy and systemic therapies in the management of endometrial cancer

• Derive the optimal surgical management of ovarian cancer based on disease stage and clinical presentation

• Assess standard and emerging therapeutic options for ovarian cancer and discuss their impact on patient outcomes

Scientific Committee

Andreas du Bois, MD, PhD Klinikum Essen Mitte Essen, Germany	Nicoletta Colombo, MD University of Milan-Bicocca Milan, Italy
Peter G. Harper, MD, FRCP Guy's and St Thomas' Hospital London, United Kingdom	Stanley B. Kaye, MD The Royal Marsden Hospital Sutton, United Kingdom
Bradley J. Monk, MD, FACS, FACOG Creighton University School of Medicine at St Joseph's Hospital and Medical Center Phoenix, Arizona, United States	Andrés Poveda, MD Fundacion Instituto Valenciano de Oncologia Valencia, Spain
Eric Pujade-Lauraine, MD, PhD Centre Hospitalier Universitaire Hotel-Dieu Paris, France	Ignace Vergote, MD, PhD University Hospital Gasthuisberg Leuven, European Union

Disclaimer

Disclosure of Conflicts of Interest

prIME Oncology assesses conflicts of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prIME Oncology is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.

Disclosure of Unlabeled Use

This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Date and Location
13 - 14 April 2012 Hotel Fira Palace Avenida Rius i Taulet, 1-3 Barcelona, Spain

Printed Materials

Continuing Education

The Accreditation Council on Oncology in Europe (ACOE) is a multidisciplinary body of full time specialists practising in the field of oncology and all recognised for their experience in education and expertise in their field. ACOE acknowledges the quality of the scientific programme and its educational value.

The ACOE accreditation label provides delegates with a guarantee of a high quality and unbiased educational activity. ACOE accredited events are awarded an agreed number of CME credit points (1 CME credit per educational hour), with a maximum of 6 credits per day. ACOE works in conjunction with the European Accreditation Council for Continuing Medical Education (EACCME®) operating under the umbrella of the European Union of Medical Specialists (UEMS). EACCME ^® acts as a clearinghouse, facilitating the accreditation endorsement by the national CME regulatory bodies.

2012 Progress and Controversies in Gynecologic Oncology Conference is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ^®) to provide the following CME activity for medical specialists. The EACCME^® is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. 2012 Progress and Controversies in Gynecologic Oncology Conference has been designated a maximum of 9 hours of European CME credits (ECMECs). The Congress operates an honour system implying that each medical specialist is expected to claim only those hours of credit that he/she actually spent at the Congress (with a maximum of 6 credits per day, 3 for a half day).

CME credits gained through participation at 2012 Progress and Controversies in Gynecologic Oncology Conference are recognised by most of the national CME authorities in Europe, which have agreed to cooperate in this European system. More information on the recognition of European credits in the European Countries, please refer to the ACOE website: www.acoe.be (select ‘CME credits recognition’).Through a mutual agreement between the UEMS and the American Medical Association (AMA), the European CME credits are also recognised towards the Physician’s Recognition Award (PRA). To convert European CME credits to AMA PRA Category 1 Credits please contact AMA at: www.ama-assn.org.

The 2012 Progress and controversies in gynecologic oncology conference has been awarded the ESMO label and 10 ESMO-MORA category 1 points. Participants will receive a certificate of attendance at the end of the meeting.